Indole amide derivatives as ep4 receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 209/08 (2006.01) A61K 31/404 (2006.01) A61K 31/416 (2006.01) A61K 31/4184 (2006.01) A61K 31/4192 (2006.01) C07D 209/12 (2006.01) C07D 209/30 (2006.01) C07D 231/56 (2006.01) C07D 235/06 (2006.01) C07D 249/18 (2006.01)

Patent

CA 2648729

The invention is directed to indole amide derivatives as EP4 receptor antagonists useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer. Pharmaceutical compositions and methods of use are also included.

L'invention concerne des dérivés d'indolamide comme antagonistes du récepteur EP4 qui sont utiles pour le traitement de maladies ou affections médiées par l'EP4, par exemple la douleur aiguë et chronique, l'ostéoarthrite, la polyarthrite rhumatoïde et le cancer. L'invention concerne également des compositions pharmaceutiques ainsi que des procédés d'utilisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Indole amide derivatives as ep4 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole amide derivatives as ep4 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole amide derivatives as ep4 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1988918

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.